Back to Search
Start Over
Role of BCL2L10 methylation and TET2 mutations in higher risk myelodysplastic syndromes treated with 5-azacytidine.
- Source :
- Leukemia (08876924); Dec2011, Vol. 25 Issue 12, p1910-1913, 4p, 3 Charts, 2 Graphs
- Publication Year :
- 2011
-
Abstract
- A letter to the editor is presented which discusses the prognostic role of TET2 mutations BCL2L10 methylation profiling on patients with high risk of myelodysplastic syndrome with 5-azacytidine.
- Subjects :
- LETTERS to the editor
METHYLATION
AZACITIDINE
THERAPEUTIC use of antimetabolites
THERAPEUTIC use of antineoplastic agents
PROTEINS
MYELODYSPLASTIC syndromes
SURVIVAL
RESEARCH
GENETIC mutation
RESEARCH methodology
PROGNOSIS
RETROSPECTIVE studies
MEDICAL cooperation
EVALUATION research
DNA methylation
COMPARATIVE studies
DNA-binding proteins
Subjects
Details
- Language :
- English
- ISSN :
- 08876924
- Volume :
- 25
- Issue :
- 12
- Database :
- Complementary Index
- Journal :
- Leukemia (08876924)
- Publication Type :
- Academic Journal
- Accession number :
- 69627590
- Full Text :
- https://doi.org/10.1038/leu.2011.170